simplyStocks
Cencora
COR · NYSEHealthcare Distribution
The economic chain
Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
$70B
P/E ratio
21×
Div yield
0.9%
EPS (FY25 GAAP)
$7.96
Profit margin
0.5%
Rev. growth
+9%
Revenue
$321B
Net income
~$1.6B
In plain English
Cencora (the former AmerisourceBergen) is one of the three giant US drug wholesalers that move most of the country's medicines: it buys in bulk from pharma manufacturers and ships more than five million products a day to pharmacies, hospitals and doctors. A razor-thin-margin logistics machine on enormous revenue, it is steadily pushing into higher-value specialty care — buying physician networks like Retina Consultants of America and OneOncology — and runs international distribution through Alliance Healthcare and World Courier.
In simple terms
What Cencora really sells
Cencora (the former AmerisourceBergen) is one of the three giant US drug wholesalers that move most of the country's medicines: it buys in bulk from pharma manufacturers and ships more than five million products a day to pharmacies, hospitals and doctors. A razor-thin-margin logistics machine on enormous revenue, it is steadily pushing into higher-value specialty care — buying physician networks like Retina Consultants of America and OneOncology — and runs international distribution through Alliance Healthcare and World Courier.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.
Risk read
SteadierMore speculative
Why this rating?